Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jonathan, Stapley"'
Autor:
Jonathan Stapley
The Power of Godliness is a key work to understand Mormon conceptions of priesthood, authority, and gender. With in-depth research and never previously used documents, Jonathan A. Stapley explores the rituals of ordination, temple'sealings,'baby bles
Autor:
Jonathan Stapley
Publikováno v:
Journal of Mormon History. 47:1-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b43d160c8c87baa8f0a3d525f56be57
https://doi.org/10.5406/jmormhist.47.4.0001
https://doi.org/10.5406/jmormhist.47.4.0001
Autor:
Fuad Ibrahimov, Parviz Allahverdiyev, Alberto Mendoza, Zahid Hasanov, Pradyumna Thiruvenkatanathan, Jonathan Stapley, Lilia Noble
Publikováno v:
SPWLA 62nd Annual Online Symposium Transactions.
This paper discusses results from the first successful de ployment of a predictive modelling technology that in forms pressure optimization procedures to help minimize sand production and increase hydrocarbon production ef ficiency in sand pron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baf726153caac9fe7e9bfbf63ba2fd70
https://doi.org/10.30632/spwla-2021-0001
https://doi.org/10.30632/spwla-2021-0001
Autor:
Jonathan Stapley
Publikováno v:
Journal of Mormon History. 44:148-150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44885f64d33f7ae06c668eea1d3aa6d6
https://doi.org/10.5406/jmormhist.44.4.0148
https://doi.org/10.5406/jmormhist.44.4.0148
Publikováno v:
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 3:113-118
Two qualitative case studies focus on the allocation of CDC funds distributed during 2002 for bioterrorism preparedness in two Texas public health regions (each as populous and complex as many states). Lessons learned are presented for public health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df74bcc303abaceaa0f142e816f0acd
https://doi.org/10.1089/bsp.2005.3.113
https://doi.org/10.1089/bsp.2005.3.113
Autor:
Hui Kuan Lin, Nicholas J. Donato, Moshe Talpaz, Ji Yuan Wu, Jonathan Stapley, Gary E. Gallick, Ralph B. Arlinghaus
Publikováno v:
Blood. 101:690-698
Clinical studies have shown that the tyrosine kinase inhibitor STI571 effectively controls BCR-ABL–positive chronic myelogenous leukemia (CML). However, disease progression while on STI571 therapy has been reported, suggesting de novo or intrinsic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0c0bb14ffed2b95fcfcd6c9e7beea6
https://doi.org/10.1182/blood.v101.2.690
https://doi.org/10.1182/blood.v101.2.690
Autor:
Nicholas J, Donato, Ji Y, Wu, Jonathan, Stapley, Hui, Lin, Ralph, Arlinghaus, Bharat B, Aggarwal, Shishir, Shishodia, Maher, Albitar, Kimberly, Hayes, Hagop, Kantarjian, Moshe, Talpaz, Shishir, Shishodin
Publikováno v:
Cancer research. 64(2)
Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase. IM resistance has been associated with kinase mutations or increased BCR-ABL expression. However, disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58bbddac3adf3861e1538ac33903e12
https://pubmed.ncbi.nlm.nih.gov/14744784
https://pubmed.ncbi.nlm.nih.gov/14744784
Publikováno v:
Science News. 163:223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b482afecf47fbcd9061632c0697c1c3
https://doi.org/10.2307/4014690
https://doi.org/10.2307/4014690